Log Out

US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist

4.210
-0.170-3.88%

Close Apr 24 16:00 ET

4.230
+0.020+0.48%

Post 18:23 ET

867.89MMarket Cap-3567P/E (TTM)

BioCryst Pharmaceuticals News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jun 15, 2023 10:19 ET
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Jun 14, 2023 11:32 ET
BioCryst Pharmaceuticals | 424B5: Prospectus
Aug 9, 2021 16:03 ET
BioCryst Pharmaceuticals | 424B2: Prospectus
May 29, 2020 06:07 ET
BioCryst Pharmaceuticals | 424B5: Prospectus
May 27, 2020 17:16 ET
BioCryst Pharmaceuticals | EFFECT: Others
May 15, 2020 00:15 ET
BioCryst Pharmaceuticals | 424B5: Prospectus
Nov 21, 2019 09:06 ET
BioCryst Pharmaceuticals | 424B2: Prospectus
Nov 14, 2019 17:25 ET
BioCryst Pharmaceuticals | 424B5: Prospectus
Nov 12, 2019 16:22 ET
BioCryst Pharmaceuticals | 424B2: Prospectus
Aug 3, 2018 16:10 ET
BioCryst Pharmaceuticals | 424B5: Prospectus
Aug 1, 2018 16:02 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 21, 2018 06:06 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 20, 2018 21:53 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 11, 2018 14:42 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 11, 2018 14:41 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 7, 2018 08:17 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 7, 2018 08:15 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 6, 2018 18:29 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 5, 2018 07:42 ET
BioCryst Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
May 9, 2018 06:35 ET

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall